story of the week
Residual ctDNA After Treatment Predicts Early Relapse in Patients With Early-Stage NSCLC
Sign in to PracticeUpdate
Only registered members have full access to PracticeUpdate content.
Additional Info
Annals of Oncology
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.
Residual ctDNA after treatment predicts early relapse in patients with early-stage non-small cell lung cancer
Ann. Oncol 2022 Feb 26;[EPub Ahead of Print], D Gale, K Heider, A Ruiz-Valdepenas, S Hackinger, M Perry, G Marsico, V Rundell, J Wulff, G Sharma, H Knock, J Castedo, W Cooper, H Zhao, CG Smith, S Garg, S Anand, K Howarth, D Gilligan, SV Harden, DM Rassl, RC Rintoul, N RosenfeldFrom MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.